BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38580802)

  • 1. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.
    Dittrich TD; Vock D; Fisch U; Hert L; Baumann SM; Kliem PSC; Rüegg S; Marsch S; De Marchis GM; Sutter R
    Neurocrit Care; 2024 Apr; ():. PubMed ID: 38580802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring.
    von Blomberg A; Kay L; Knake S; Fuest S; Zöllner JP; Reif PS; Herrmann E; Balaban Ü; Schubert-Bast S; Rosenow F; Strzelczyk A
    CNS Drugs; 2020 May; 34(5):545-553. PubMed ID: 32219682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
    Brigo F; Nardone R; Tezzon F; Trinka E
    Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
    Kay L; Reif PS; Belke M; Bauer S; Fründ D; Knake S; Rosenow F; Strzelczyk A
    Epilepsia; 2015 Sep; 56(9):1408-14. PubMed ID: 26216711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, randomized, placebo-controlled trial.
    Spencer DC; Sinha SR; Choi EJ; Cleveland JM; King A; Meng TC; Pullman WE; Sequeira DJ; Van Ess PJ; Wheless JW
    Epilepsia; 2020 Nov; 61(11):2415-2425. PubMed ID: 33140403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.
    Detyniecki K; Van Ess PJ; Sequeira DJ; Wheless JW; Meng TC; Pullman WE
    Epilepsia; 2019 Sep; 60(9):1797-1808. PubMed ID: 31140596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal midazolam as first-line inhospital treatment for status epilepticus: a pharmaco-EEG cohort study.
    Kay L; Merkel N; von Blomberg A; Willems LM; Bauer S; Reif PS; Schubert-Bast S; Rosenow F; Strzelczyk A
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2413-2425. PubMed ID: 31682078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.
    Meng TC; Szaflarski JP; Chen L; Brunnert M; Campos R; Van Ess P; Pullman WE; Fakhoury T
    Epilepsy Behav; 2023 Jan; 138():108989. PubMed ID: 36410152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.
    Charalambous M; Bhatti SFM; Van Ham L; Platt S; Jeffery ND; Tipold A; Siedenburg J; Volk HA; Hasegawa D; Gallucci A; Gandini G; Musteata M; Ives E; Vanhaesebrouck AE
    J Vet Intern Med; 2017 Jul; 31(4):1149-1158. PubMed ID: 28543780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study.
    Charalambous M; Volk HA; Tipold A; Erath J; Huenerfauth E; Gallucci A; Gandini G; Hasegawa D; Pancotto T; Rossmeisl JH; Platt S; De Risio L; Coates JR; Musteata M; Tirrito F; Cozzi F; Porcarelli L; Corlazzoli D; Cappello R; Vanhaesebrouck A; Broeckx BJG; Van Ham L; Bhatti SFM
    J Vet Intern Med; 2019 Nov; 33(6):2709-2717. PubMed ID: 31580527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.
    McTague A; Martland T; Appleton R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD001905. PubMed ID: 29320603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
    Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
    Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evaluation of the Efficacy and Safety of Midazolam Nasal Spray in Patients With Seizure Clusters: A Systematic Review and Meta-Analysis.
    Niraj N; Mahajan S; Prakash A; Sarma P; Medhi B
    Cureus; 2023 Jan; 15(1):e34064. PubMed ID: 36843713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit.
    Owusu KA; Dhakar MB; Bautista C; McKimmy D; Cotugno S; Sukumar N; Deng Y; Farooque P; Hirsch LJ; Maciel CB
    Epilepsy Behav; 2019 Sep; 98(Pt A):161-167. PubMed ID: 31374472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose midazolam infusion for refractory status epilepticus.
    Fernandez A; Lantigua H; Lesch C; Shao B; Foreman B; Schmidt JM; Hirsch LJ; Mayer SA; Claassen J
    Neurology; 2014 Jan; 82(4):359-65. PubMed ID: 24363133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters.
    Wheless JW
    Expert Rev Neurother; 2021 Nov; 21(11):1195-1205. PubMed ID: 33593228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.